Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma

Obstetrics and Gynecology

Volumn 95, Issue 4, 2000, Pages 548-552

  Abulafia, Ovadia ^a   Ruiz, Jose E ^a   Holcomb, Kevin ^a   Dimaio, Therese M ^b   Lee, Yi Chun ^a   Sherer, David M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MICROVASCULATURE; OVARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS;

EID: 0034097112     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00608-0     Document Type: Article

References (23)

1. Folkman J. Tumor angiogenesis. Adv Cancer Res. 43:1985;175-203.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6.
3. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis Correlation in invasive breast carcinoma . N Engl J Med. 324:1991;1-8.
4. Strivastava A., Laidler P., Davies R.P., Horgan K., Hughes L.E. The prognostic significance of tumor vascularity in intermediate thickness (0.76-4 mm thick) skin melanoma. Am J Pathol. 133:1988;413-423.
5. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., Luna N., Morgan E., Yang J.J., et al. Angiogenesis factor in endometrial carcinoma A new prognostic indicator . Am J Obstet Gynecol. 174:1996;1879-1884.
6. Macchiarini P., Fontani G., Hardin M.J., Squartini F., Angeletti C.A. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet. 340:1992;145-146.
7. Olivarez D., Wilbroght T., DeRiese W., Foster R., Reister T., Einhorn L., et al. Neovascularization in clinical stage A testicular germ cell tumor prediction of metastatic disease. Cancer Res. 54:1994;2880-2882.
8. Dickinson A.J., Fox S.B., Persad A.A., Hollyee J., Sibley G.N., Harris A.L. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder cancer. Br J Urol. 74:1994;762-766.
9. Weidner N., Carroll P.R., Flax J., Blimenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
10. Obermair A., Kohlberger P., Bancher-Todesca D., Temper C., Slutz G., Leodolter S., et al. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol. 63:1996;204-209.
11. Wiggins D.L., Granai C.O., Steinhoff M.M., Calabresi P. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol. 56:1995;353-356.
12. Abulafia O., Triest W.E., Sherer D.M. Angiogenesis in primary and metastatic ovarian epithelial carcinoma. Am J Obstet Gynecol. 177:1997;541-547.
13. Hollingsworth H.C., Kihn E.C., Steinberg S.M., Rothenberg M.L., Merino M.J. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol. 147:1995;33-41.
14. Yamamoto S., Konishi I., Koruda H., Nanbu K., Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasm Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels . Br J Cancer. 76:1997;1221-1227.
15. Paley P.J., Staskus K.A., Gebhard K., Mohnraj D., Twiggs L.B., Carson L.F., et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 80:1997;98-106.
16. Schoell W.M., Pieber D., Riech O., Lahousen M., Janiek M., Guecer F., et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma. Cancer. 80:1997;2257-2262.
17. Staging announcement. Gynecol Oncol. 26:1986;383.
18. Mietinnen M., Lindenmyer A.E., Chaubal A. Endothelial cell marker CD31, CD34, BNH9 antibody to H- and Y-antigen Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor . Mod Pathol. 7:1994;82-90.
19. Brem S.S., Jensen H.M., Gullino P.M. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer. 41:1978;239-244.
20. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
21. Ishiwata I., Ishiwata C., Soma M., Ono I., Nakaguchi T., Ishikawa H. Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane. Gynecol Oncol. 29:1988;87-93.
22. Boocock C.A., Charnock-Jones S., Sharkey A.M., McLaren J., Barker P.J., Wright K.A., et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst. 87:1995;506-516.
23. Brustmann H., Riss P., Naudé S. The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary A quantitative histologic study . Gynecol Oncol. 67:1997;20-26.